Interestingly, LY6K from clinical data demonstrated that overexpression of LY6K leads to a few organ cancers, including breast cancer, esophageal squamous cancer, gingivobuccal cancers, bladder cancer, and lung cancer (Upadhyay, 2019). Here, LY6K is linked to urinary bladder carcinoma.